Medico Reach

AUGUST 12, 2022

billion In operation since: 2008 Biosplice Therapeutics aims to restore health by harnessing alternative splicing and offering therapy. billion In operation since: 2008 Caris Life Sciences aims to revolutionize cancer care. Website: www.tempus.com. Osam Kibar. Company: Biosplice Therapeutics Age: 48 years (1974 born) Net worth : $2.9

Healthcare 98

Healthcare Healthcare Healthcare Provider Engineering 98

pharmaphorum

FEBRUARY 13, 2024

The alliance is with Roche Tissue Diagnostics (RTD), a unit of the Swiss pharma group that is concerned with the development of tissue-based tools to improve the diagnosis of cancer and grew out of Roche’s acquisition of Venta Medical Systems in 2008.

Pharma 69

Pharma Medical Patients 69

Healthcare Success

APRIL 3, 2025

Johnson & Johnson (2008 Recession) 4.3% revenue increase in 2008, and a 26.5% CVS Health (2008 Recession) 14.6% revenue increase in 2008, and a 21.8% These decisions also helped improve consumer trust and brand loyalty. net income boost post-recession. boost in net earnings.

Marketing 59

Marketing Healthcare Healthcare Media 59

World of DTC Marketing

JANUARY 12, 2021

While these numbers may pale in comparison with the 18-29 (86%) and 30-49 (61%) groups, it should be noted that as of November 2008 (a short time ago) only 16% of the 50-64-year-old group and 4% of the 65+ group were using Facebook. This represents 31% of all seniors in the US.

Patients 170

Patients Media Marketing Prescription 170

Pharmaceutical Technology

OCTOBER 10, 2024

According to Lancet Public Health, the incidence of probable food allergy more than doubled in England between 2008 and 2018.

Food 52

Food 52

pharmaphorum

JULY 21, 2022

” There will be no dramatic change in direction at Roche under the new CEO, according to Schwan, who was named CEO way back in 2008 and has been at the company throughout his entire career, joining the company in the early 1990s.

Sales 119

Sales Pharma Competition Management 119

PharmaTech

NOVEMBER 1, 2024

The system is Hapman’s first major product launch since 2008, following a year of intensive R&D that builds upon the company’s eight decades of tubular drag conveyor expertise.

52

52

PM360

JUNE 18, 2025

About PM360 Editorial Advisory Board Contact PM360 Press Releases Privacy Policy and Terms of Service Subscribe to PM360 Reprints PM360 Media Kit – Advertise With Us PM360 Editorial Calendar Article Submission Information Internships ©2008-2023 AMS Group LLC. Click to continue to site. × Forgotten Password?

Pharma 52

Pharma Marketing Media Medical 52

Evolve Your Success

AUGUST 28, 2024

In 2008 he created the Badia Hand to Shoulder Center, having previously co-founded the Miami Hand Center, and Surgery Center at Doral. This international meeting was held at the renowned Miami Anatomical Research Center (M.A.R.C.), which Badia co-founded in 2005.

Media 130

Media Healthcare Healthcare Medical sales 130

Legacy MEDSearch

MAY 3, 2023

Leadership includes Joy Celebre (recruiting since 1996, joined in 2008), Carolyn Jones (recruiting since 1995, joined in 2011), Arshad Alam (recruiting since 1995, joined 2017), John White (Talent Sourcing Manager, joined 2012), and Partner Chris Miclot, (joined 2012).

Recruitment 98

Recruitment Medical Management Media 98

European Pharmaceutical Review

APRIL 3, 2023

In 2008, the ALK gene was found to hold a key role in the disease. Lorlatinib – could it change standard treatment for neouroblastoma? “This is in a population known to have inferior survival with standard-of-care, high-risk therapy,” Goldsmith explained.

Food and Drug Administration 97

Food and Drug Administration Medicine Patients Food 97

European Pharmaceutical Review

DECEMBER 12, 2024

2008; 28(6A):35673572. Int J Gynecol Cancer. 2022; 32(6). Markert S, Lassmann S, Gabriel B, et al. Alpha-Folate Receptor Expression In Epithelial Ovarian Carcinoma And Non-Neoplastic Ovarian Tissue. Anticancer Res. The post Targeting ovarian cancer with a novel antibody therapeutic appeared first on European Pharmaceutical Review.

Medicine 98

Medicine Medical Networking Pharmaceutical 98

European Pharmaceutical Review

FEBRUARY 2, 2023

The last paracetamol plant in Europe, closed in France in 2008 as it was no longer economically sustainable, marking the exit of paracetamol manufacturing from Europe” The closure of API manufacturing plants in Europe started in earnest 15 years ago.

Medicine 111

Medicine Manufacturing Pharmaceutical Specialization 111

Impetus Digital

APRIL 6, 2023

Yeadon sits down with host Greg Muzzillo from the Million Dollar Podcast to share how she took a leap of faith by founding a virtual-based company in 2008, and has since transformed pharmaceuticals meetings, events, and programs across the globe.

Pharmaceutical 52

Pharmaceutical Professional Services Healthcare Provider Consulting 52

pharmaphorum

OCTOBER 12, 2022

Albani and his cofounder Berent Prakken have been working in this field since 2008, applying translational thinking to the many seismic shifts that have happened in that time. The objective is to transform what is a whole series of tug-of-wars into rowing together.”. Translational medicine and digital health.

Medicine 111

Medicine Training Education Healthcare 111

Pharmacy Times

DECEMBER 8, 2022

Study finds textured breast implants do not increase the risk of anaplastic large-cell lymphoma, which has grown in incidence since 2008.

29

29

pharmaphorum

JANUARY 4, 2023

The drug was originally developed by CV Therapeutics – bought by Gilead in 2009 – and first launched in the US in 2008. According to IQVIA figures, US sales of Lexiscan were approximately $650 million for the 12 months that ended 31 March 2022, making it one of Astellas’ top products. It is sold as Rapiscan in Europe by GE Healthcare.

Pharmacology 59

Pharmacology Marketing Pharma Competition 59

pharmaphorum

SEPTEMBER 21, 2022

billion buyout of Millennium Pharma way back in 2008 – but those were dashed in 2015 when the drug failed to move the needle in a trial involving patients with peripheral T-cell lymphoma (PTCL). Takeda is also in line for just over $287 million in potential milestone payments, plus royalties on net sales if it reaches the market.

Patients 64

Patients Sales Pharma Marketing 64

Salesforce

MARCH 3, 2022

After the accident in 2008, Schultz was anxious to get back into sports, but struggled to find prosthetics to support extreme movement. Turning data into insights: how activity data replaces trial and error. But I’m a garage guy,” he said. “I

Specialization 98

Specialization Competition Medical 98

Legacy MEDSearch

APRIL 11, 2023

About Moximed Moximed was founded in 2008 and is dedicated to helping people with mild to moderate osteoarthritis preserve their knee joints while living healthy, active lives. For these patients, total knee replacement is a reluctant option, as it is an end-stage treatment for end-stage disease.

Marketing 96

Marketing FDA Food and Drug Administration Specialization 96

PM360

FEBRUARY 12, 2024

This February we celebrate the 16th annual Rare Disease Day , established in 2008, to raise awareness of the more than 7,000 identified rare diseases worldwide. Rare Disease Day is observed annually on the “rarest” day of the year, February 28th or 29th depending on leap years.

Food and Drug Administration 105

Food and Drug Administration Patients Medical Networking 105

pharmaphorum

NOVEMBER 1, 2022

In 2008, the startup launched its first API to make and receive phone calls entirely in the cloud. Widespread adoption of these protocols allows every stakeholder in the environment to expect a well-defined behaviour when interfacing digitally with one another. The power of the open-protocol approach has been realised across many industries.

Patients 98

Patients Electronics Healthcare Healthcare 98

pharmaphorum

SEPTEMBER 26, 2022

It was first launched in the US in 2008. According to IQVIA figures, US sales of Lexiscan were approximately $650 million for the 12 months that ended 31 March 2022, making it one of Astellas top products. ” Hospira isn’t the only generics company trying to bring a version of regadenoson to the US market.

Pharmacology 52

Pharmacology Marketing FDA Pharma 52

Clarivate

OCTOBER 4, 2023

The Solution: Unified IP lifecycle management In 2008, Philips turned to ipan, now part of Clarivate , to handle renewals. Next to that Philips is also quite active in registering new design rights and trademarks. All the formalities in relation to filing and prosecution are handled by the IP Support group.” ” de Haan explains.

Management 59

Management Networking Leads Patients 59

European Pharmaceutical Review

JUNE 12, 2024

2017; 55(7):1998-2008. Peng Z, Jin D, Kim HB, et al. Update on Antimicrobial Resistance in Clostridium difficile: Resistance Mechanisms and Antimicrobial Susceptibility Testing. J Clin Microbiol. About the author Dr Olaia Aurtenetxe is the Head of Clinical Research at Mikrobiomik.

Safety 111

Safety Side effects Patients Healthcare 111

pharmaphorum

JANUARY 9, 2023

Albireo – which spun out of AstraZeneca in 2008 and was formally based in Sweden – has said it thinks Bylvay has the potential to become a $1 billion-plus product if approved for all three of its target indications. FDA approval in this indication would unlock the additional $10 CVR payment, providing it takes place before the end of 2027.

Transportation 52

Transportation Sales Leads FDA 52

pharmaphorum

JULY 15, 2022

Things became litigious in 2017, when a Delaware court found that Teva’s label for its generic encouraged doctors to use the drug to treat heart failure in a way that infringed GSK’s RE40,000 patent, which was reissued by the Patent and Trademark Office (PTO) in 2008.

Prescription 52

Prescription Doctors Marketing Government 52

The Brooks Group

OCTOBER 14, 2019

Companies who proactively recognized the threat ahead of the 2008 recession achieved six percentage points better Total Shareholder Return in the downturn than companies that did not address the challenge early. Now is the time to begin “building a moat” around your organization and safeguarding from uncertainty.

Sales 60

Sales Competition Sales process Prospecting 60

Nixon Gwilt Law

FEBRUARY 27, 2023

How the New DEA Proposal for Tele-Prescribing Differs from the PHE Waivers and Flexibilities Outside of the Public Health Emergency (PHE), which is set to expire on May 11, 2023, current DEA regulations based on the Ryan Haight Online Pharmacy Consumer Protection Act of 2008 (the “Ryan Haight Act”) prohibit tele-prescribing controlled substances for (..)

Prescription 105

Prescription Medical Patients Specialization 105

Legacy MEDSearch

SEPTEMBER 28, 2023

About 4WEB Medical 4WEB Medical, founded in 2008 in Dallas, TX, is an orthopedic implant company. We are excited to launch several new cervical products before the end of the year and look forward to capitalizing on this success with significant growth in 2024,” said Geoff Bigos, Vice President of 4WEB Medical’s Spine Division.

Medical 52

Medical Marketing Recruitment Management 52

Clarivate

JULY 27, 2023

GPON standards were finalized by ITU-T in 2003 and their mass deployment started around 2008. PON provides last mile connectivity typically called FTTx, depending on where the optical fiber terminates. Later, 10Gigabit capable PON standards emerged between 2010 and 2017 addressing increasing bandwidth needs.

Networking 52

Networking Distribution Media Management 52

Evolve Your Success

JUNE 28, 2022

It was 2007 and 2008. It was June of 2008. This was from 2008 to 2014. McCormack , who had been my customer that is a spine surgeon in San Francisco, calls me out of the blue and was like, “I want to tell you about an idea.” That became Providence Medical Technology. What year was this? I wrote a post on this on LinkedIn.

Sales 130

Sales Pharma Medical sales reps Medical sales 130

Pharmaceutical Technology

OCTOBER 5, 2008

Daiichi Sankyo’s move to acquire Ranbaxy is, according to Dealogic’s research, the second-biggest outbound M&A so far in 2008, with a deal worth $5,326m. “Local generic companies such as Ranbaxy and DRL have expanded through acquisition in Western markets aggressively in 2006.” % increase).

Government 40

Government Marketing Pharmaceutical Physicians 40

Medgadget

JANUARY 20, 2023

After selling the company in 2008, I got into footwear and later became President of Teva Footwear. I had a fairly active life working in the mountains and it was common for our staff meetings to be on a chairlift or on a trail. We worked hard and played hard. Simply put, I lost my mojo.

Engineering 97

Engineering Marketing Leads 97

pharmaphorum

NOVEMBER 11, 2022

Viehbacher led Sanofi between 2008 and 2014 and has decades of experience with both large pharmaceutical companies and small biotechs. Six months after Biogen began its search for new leadership, the biotech has now named former Sanofi chief executive Christopher Viehbacher as Michel Vounatsos’ replacement, effective from 14 th November.

Insurance 40

Insurance Doctors FDA Pharma 40

Clarivate

JULY 10, 2024

However, Fisher’s idea started to gain more traction among economists in the mid-1970s and may have influenced the responses of key policymakers during the 2008 financial crisis. It didn’t receive much attention at the time, partially because the economic theories of John Maynard Keynes were favored.

Consulting 69

Consulting Medicine Government Marketing 69

Copyright Clearance Center

APRIL 11, 2024

Before joining the Vanderbilt Law faculty in 2008, Gervais served as acting dean and vice-dean for research of the Common Law Section at the University of Ottawa. In 2012, he was the Gide Loyrette Nouel Visiting Chair at Sciences Po Law School in Paris and became the first North American law professor admitted to the Academy of Europe.

Government 52

Government Leads Consulting Training 52